financing

News

Earlybird principal Dr Christoph Massner

VC Earlybird Health raises €173m for healthtech companies

Venture capital group Earlybird has launched its second health fund with €173 million ($185 million) at its disposal to fund companies in the health technology area, more

News

Dermatology pharma Alys launches with $100m from Medicxi

European life sciences investor Medicxi has bundled together six privately-held companies with dermatology medicines in development under a single drugmaker – called Alys

News

BioNTech adds CAR-T manufacturing with $250m Autolus deal

Germany’s BioNTech has taken a $200 million stake in Autolus in a private placement that will allow it to tap into the UK company’s manufacturing capacity for CAR-T therap

News

Kyverna prices its IPO, seeking $319m for its cell therapies

Kyverna Therapeutics has announced the pricing of its initial public offering, and in another sign of the improving biotech financing environment has raised its target pro

News

Metagenomi prices IPO and NeOnc joins list of hopefuls

Gene editing start-up Metagenomi and cancer specialist NeOnc Technologies have announced the terms of their initial public offerings, in another sign that investor interes

News

Vera prices $250m offer, and other biotech financings

Our round-up of recent biotech financings is headed by a $250 million public offering for late clinical-stage biotech Vera Therapeutics, with an initial public offering (I

VC Earlybird Health raises €173m for healthtech companies

Dermatology pharma Alys launches with $100m from Medicxi

BioNTech adds CAR-T manufacturing with $250m Autolus deal

Kyverna prices its IPO, seeking $319m for its cell therapies

Metagenomi prices IPO and NeOnc joins list of hopefuls

Vera prices $250m offer, and other biotech financings

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

financing

Editor's Picks